Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Foghorn Therapeutics (FHTX) Return on Invested Capital (2023 - 2024)

Foghorn Therapeutics (FHTX) has 2 years of Return on Invested Capital data on record, last reported at 5.0% in Q3 2024.

  • For Q3 2024, Return on Invested Capital rose 281.0% year-over-year to 5.0%; the TTM value through Sep 2024 reached 5.0%, up 281.0%, while the annual FY2023 figure was 2.93%, N/A changed from the prior year.
  • Return on Invested Capital reached 5.0% in Q3 2024 per FHTX's latest filing, up from 1.8% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 10.07% in Q1 2023 and bottomed at 1.23% in Q1 2024.